Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': [ESMO Open volume 9 issue 6 (2024) 103476].
T KoyamaN KiyotaS BokuY ImamuraN ShibataH SatakeK TanakaH HayashiT OnoeY AsadaT YamazakiT NoseS OhataY NagataniS KimbaraY FunakoshiM TeshimaH ShinomiyaH MinamiPublished in: ESMO open (2024)